KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Restructuring Costs (2019)

Twist Bioscience (TWST) has disclosed Restructuring Costs for 1 consecutive years, with $22.5 million as the latest value for Q4 2019.

  • Quarterly Restructuring Costs changed N/A to $22.5 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $22.5 million through Sep 2020, changed N/A year-over-year, with the annual reading at $22.5 million for FY2020, N/A changed from the prior year.
  • Restructuring Costs for Q4 2019 was $22.5 million at Twist Bioscience.
  • The five-year high for Restructuring Costs was $22.5 million in Q4 2019, with the low at $22.5 million in Q4 2019.